Skip to Content

What types of Hepatitis C does Mavyret treat?

Medically reviewed by Judith Stewart, BPharm. Last updated on Feb 11, 2021.

Official Answer

by Drugs.com

Mavyret (glecaprevir and pibrentasvir) is an oral treatment for all chronic hepatitis C virus (HCV) genotypes (1-6) in adult and pediatric patients 12 years and older.

Mavyret is FDA-approved for the treatment of adult and pediatric patients 12 years and older or weighing at least 45 kg with:

  • chronic HCV genotype (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A).
  • HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor, but not both.

Related Medical Questions

Drug Information

Related Support Groups